Company / Total Assets
Ginkgo Bioworks Holdings, Inc. Total Assets History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$1.1B
FY2025
5-year range
$1.1B / $2.5B
FY2021-FY2025
Trend
-18.7%
vs FY2024
Sector context
#77 of 216
Health Care
What the data says
At $1.1B, Ginkgo Bioworks Holdings, Inc.'s total assets ranks #77 of 216 in the Health Care sector. Total Assets has declined for 3 consecutive years, from $2.5B in FY2022 to $1.1B in FY2025.
Based on SEC 10-K filings.
$1.1B in FY2025 with a 5-year CAGR of +10.6%.
Declined from $1.7B to $1.1B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- -23.9%
- 5-Year CAGR
- +10.6%
- 10-Year CAGR
- -
Sector benchmark
#77 of 216 in Health CareTop 36% of 216This company $1.1B Sector average $7.4B
▼
-85.0% below sector average
Key checks
Key Insights
- Ginkgo Bioworks Holdings, Inc.'s total assets has declined for 3 consecutive years.
- 5-year CAGR of +10.6%, indicating consistent growth.
- In FY2025, total assets decreased 18.7% year-over-year.
- Ranks #77 out of 216 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.1B | -18.7% |
| FY2024 | $1.4B | -17.3% |
| FY2023 | $1.7B | -34.4% |
| FY2022 | $2.5B | +22.6% |
| FY2021 | $2.1B | +206.7% |
| FY2020 | $675.2M | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026